What is Nuvalent, Inc.'s change in AP?

Nuvalent, Inc. (NUVL) reported change in AP of -$7.69M in Q1 2026.

How has Nuvalent, Inc.'s change in AP changed year-over-year?

Nuvalent, Inc.'s change in AP decreased by 136.7% year-over-year, from $20.94M to -$7.69M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Nuvalent, Inc. NUVL Change in AP

Change in AP at other companies

PfizerPFE

-$117.25M+54.2%

ImmunityBio, Inc.IBRX

$3.9M-39.4%

Summit TherapeuticsSMMT

$6.8M+1,811%

ExelixisEXEL

-$17.9M-311%

Revolution Medicines, Inc.RVMD

$16.86M+304%

IncyteINCY

$23.45M+1,186%

Other financials

Income statement

See full

Operating income-$119.4M-25.9%

Net income-$109.3M-29.2%

EPS (diluted)-$1.39-17.8%

Balance sheet

See full

Cash & equivalents$159.7M+32.2%

Total equity$1.2B+16.2%

Total assets$1.3B+20.4%

Cash flow

See full

Operating cash flow-$92.4M-68.5%

Valuation

See full

Market cap$9.77B+58.6%

Returns & leverage

See full

Return on equity-41.2%+7.5pp

Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nuvalent, Inc.'s change in AP?: Nuvalent, Inc. (NUVL) reported change in AP of -$7.69M in Q1 2026.
How has Nuvalent, Inc.'s change in AP changed year-over-year?: Nuvalent, Inc.'s change in AP decreased by 136.7% year-over-year, from $20.94M to -$7.69M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.